SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-08-065952
Filing Date
2008-03-26
Accepted
2008-03-26 17:25:07
Documents
8
Period of Report
2007-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 1498183
2 STATEMENT RE: COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES dex121.htm EX-12.1 16745
3 SUBSIDIARIES OF THE REGISTRANT dex211.htm EX-21.1 933
4 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM dex231.htm EX-23.1 1681
5 CERTIFICATION OF CHIEF EXECUTIVE OFFICER dex311.htm EX-31.1 7119
6 CERTIFICATION OF CHIEF FINANCIAL OFFICER dex312.htm EX-31.2 7220
7 CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER dex32.htm EX-32 6644
8 GRAPHIC g14888g83v40.jpg GRAPHIC 59906
  Complete submission text file 0001193125-08-065952.txt   1622626
Mailing Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119
Business Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119 2062707100
CELL THERAPEUTICS INC (Filer) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-12465 | Film No.: 08712899
SIC: 2834 Pharmaceutical Preparations